Credit Suisse’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-20,995
| Closed | -$107K | – | 3627 |
|
|
2019
Q3 | $107K | Buy |
+20,995
| New | +$107K | ﹤0.01% | 3287 |
|
|
2019
Q2 | – | Sell |
-21,149
| Closed | -$151K | – | 3526 |
|
|
2019
Q1 | $151K | Buy |
21,149
+2,353
| +13% | +$16.8K | ﹤0.01% | 3215 |
|
|
2018
Q4 | $161K | Buy |
18,796
+2,001
| +12% | +$17.1K | ﹤0.01% | 3172 |
|
|
2018
Q3 | $337K | Sell |
16,795
-18,712
| -53% | -$375K | ﹤0.01% | 3003 |
|
|
2018
Q2 | $917K | Buy |
35,507
+8,764
| +33% | +$226K | ﹤0.01% | 2640 |
|
|
2018
Q1 | $640K | Buy |
26,743
+1,408
| +6% | +$33.7K | ﹤0.01% | 2826 |
|
|
2017
Q4 | $859K | Sell |
25,335
-7,543
| -23% | -$256K | ﹤0.01% | 2639 |
|
|
2017
Q3 | $697K | Buy |
+32,878
| New | +$697K | ﹤0.01% | 2880 |
|
|
2016
Q4 | – | Sell |
-16,817
| Closed | -$276K | – | 3836 |
|
|
2016
Q3 | $276K | Sell |
16,817
-18,299
| -52% | -$300K | ﹤0.01% | 3350 |
|
|
2016
Q2 | $532K | Sell |
35,116
-8,566
| -20% | -$130K | ﹤0.01% | 3087 |
|
|
2016
Q1 | $632K | Buy |
43,682
+36,018
| +470% | +$521K | ﹤0.01% | 2790 |
|
|
2015
Q4 | $217K | Sell |
7,664
-9,250
| -55% | -$262K | ﹤0.01% | 3620 |
|
|
2015
Q3 | $283K | Sell |
16,914
-1,139
| -6% | -$19.1K | ﹤0.01% | 3543 |
|
|
2015
Q2 | $473K | Buy |
+18,053
| New | +$473K | ﹤0.01% | 3495 |
|